New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
11:37 EDTMDT, EWEdwards Lifesciences weakness a buying opportunity, says Canaccord
Canaccord said Edwards Lifesciences is down following Metronic's (MDT) FDA approval for the CoreValve TAVI system, which was a few months earlier than expected but in line with guidance. The analyst continues to expect the FDA's approval of Edwares Lifesciences' SAPIEN XT by mid-2014 but could actually be sooner following the Medtronic's approval. The firm continues to recommend Edwards Lifesciences and reiterates its Buy rating and $78 price target.
News For EW;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
07:10 EDTMDTMedtronic's Solitaire improved neurological outcomes in stroke patients in trial
Subscribe for More Information
April 14, 2015
11:04 EDTMDTMedtronic to develop stent graft system under patent agreement with Sanford
Subscribe for More Information
09:16 EDTMDTMedtronic announces CE Mark for Micra TPS
Subscribe for More Information
April 13, 2015
17:13 EDTMDTIBM Medtronic to partner to improve diabetes care
IBM (IBM) and Medtronic (MDT) announced that they will work together to combine powerful analytics and cognitive computing with diabetes medical devices and health data to develop a new generation of personalized diabetes management solutions. People using Medtronic diabetes solutions could benefit from new solutions developed in collaboration with IBM's newly-formed Watson Health unit.
17:10 EDTMDTIBM establishes a Watson Health Cloud
Subscribe for More Information
April 10, 2015
15:37 EDTMDTMedtronic looking to sell medical supplies business, dealReporter says
Subscribe for More Information
07:35 EDTEW, MDTExpert comments bullish for Edwards, Medtronic, says RBC Capital
Subscribe for More Information
April 8, 2015
07:24 EDTMDTNeurotechnology Industry Organization to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use